Background-Ventricular restraint is a nontransplantation surgical treatment for heart failure. The effect of varying restraint level on left ventricular (LV) mechanics and remodeling is not known. We hypothesized that restraint level may affect therapy efficacy. Methods and Results-We studied the immediate effect of varying restraint levels in an ovine heart failure model. We then studied the long-term effect of restraint applied over a 2-month period. Restraint level was quantified by use of fluid-filled epicardial balloons placed around the ventricles and measurement of balloon luminal pressure at end diastole. At 4 different restraint levels (0, 3, 5, and 8 mm Hg), transmural myocardial pressure (P tm ) and indices of myocardial oxygen consumption (MV O 2 ) were determined in control (nϭ5) and ovine heart failure (nϭ5). Ventricular restraint therapy decreased P tm and MV O 2 , and improved mechanical efficiency. An optimal physiological restraint level of 3 mm Hg was identified to maximize improvement without an adverse affect on systemic hemodynamics. At this optimal level, end-diastolic P tm and MV O 2 indices decreased by 27% and 20%, respectively. The serial longitudinal effects of optimized ventricular restraint were then evaluated in ovine heart failure with (nϭ3) and without (nϭ3) restraint over 2 months. Optimized ventricular restraint prevented and reversed pathological LV dilatation (130Ϯ22 mL to 91Ϯ18 mL) and improved LV ejection fraction (27Ϯ3% to 43Ϯ5%). Measured restraint level decreased over time as the LV became smaller, and reverse remodeling slowed. Conclusions-Ventricular restraint level affects the degree of decrease in P tm , the degree of decrease in MV O 2 , and the rate of LV reverse remodeling. Periodic physiological adjustments of restraint level may be required for optimal restraint therapy efficacy.
V entricular restraint is a nontransplantation surgical treatment for heart failure (HF) in which both ventricles are wrapped with material designed to mechanically constrain the ventricles. 1, 2 The intent is to provide passive end-diastolic support to constrain ventricular size without pathological diastolic restriction. Numerous studies have demonstrated that passive ventricular restraint may prevent or reverse left ventricular (LV) dilation and remodeling in HF. [3] [4] [5] [6] [7] [8] The precise mechanics of this, however, are not known. Our hypothesis is that ventricular restraint decreases transmural myocardial pressure (P tm ) by pressure application on the epicardium at end diastole. This hypothesis has never been documented because current restraint devices do not allow for the measurement of restraint level or P tm . 9, 10 In addition, definitive studies that evaluate the effect of alteration of restraint level on ventricular mechanics have not yet been performed, and no criteria exist to optimize restraint therapy in a physiological manner to maximize LV performance.
Clinical Perspective p 1210
Our hypothesis is that ventricular restraint unloads the LV and reduces P tm and myocardial oxygen consumption (MV O 2 ). We also hypothesize that restraint level affects therapeutic efficacy, and that, as the LV size decreases, the effective restraint level will decrease as an indication of LV improvement. To evaluate these questions, we developed an adjustable fluid-filled balloon to quantitatively apply restraint to the entire epicardial surface of both ventricles. With this new technique-quantitative ventricular restraint (QVR)-both the direct measurement of P tm and the quantitative application of ventricular restraint are possible.
Methods

Study Design Overview
This study was divided into 2 parts. In part I, we evaluated the immediate effect of ventricular restraint on P tm and indices of MV O 2 in normal (nϭ5) and HF ovines (nϭ5). To produce failure, ovines underwent first (D1) and second (D2) diagonal coronary artery ligation. HF, defined as an LV ejection fraction (EF) Ͻ35% and a 100% increase in LV end-diastolic volume (EDV), developed 2 months after ligation. All animals underwent placement of QVR balloons over the ventricular epicardium in a terminal study. The effect of ventricular restraint level on P tm , indices of MV O 2 , systolic contractility, and systemic hemodynamics in normal and HF ovines was determined. We then identified an optimal restraint level that maximized improvement in P tm and indices of MV O 2 and minimized adverse effects on systemic hemodynamics.
In part II, optimized QVR was applied in a 4-month longitudinal study in HF ovines to assess the long-term effect of restraint on LV EDV, EF, and the level of restraint itself. In this long-term study, 6 ovines underwent D1/D2 ligation and developed HF 2 months postligation. After the development of HF, 3 animals underwent QVR balloon implantation at the optimal restraint level and 3 animals underwent no device implantation as the control group. All animals were then followed up for an additional 2 months with serial echocardiography. In the QVR animals, restraint level was measured weekly. Throughout the study period, the QVR balloon volume was not adjusted. At termination, fluid was withdrawn from the QVR balloon and measured to verify that any changes in restraint level were not caused by a leak in the balloon.
A total of 16 adult male ovines (30 to 40 kg) were used for this study. All animals received humane care in compliance with the Guide for Care and Use of Laboratory Animals published by the National Institutes of Health (NIH publication 86-23, revised 1996). The protocol was approved by the Institutional Animal Care and Use Committee at Harvard Medical School.
Quantitative Ventricular Restraint Balloons
We designed and constructed a half-ellipsoidal balloon from medical-grade polyurethane sheets (Polyzen, Apex, NC; Figure 1 ). Each balloon was composed of two 1-mm-thick layers. An access line was placed between the 2 layers to allow pressure measurement inside the balloon lumen and the addition or withdrawal of fluid. The outer layer of the balloon was composed of a flexible but inelastic polyurethane layer. Because the outer layer of the balloon is inelastic but flexible, fluid introduced into the balloon lumen has only one direction of filling space-inward toward the epicardial surface. This creates a tighter wrap. Conversely, withdrawal of fluid from the balloon lumen results in a looser wrap. The balloon access line was connected to an implantable portacath (Bard Access Systems). The port was accessed with an 18-gauge Huber needle and connected to a Statham P10EZ pressure transducer (SpectraMed, Oxford, Calif). Measurement of the luminal pressure inside the balloon when the heart is largest in volume-end diastole-allows wrap tightness to be precisely quantified. At end diastole, the pressure inside the balloon is solely a function of heart volume plus the fluid volume and the mechanical properties of the outer layer. We previously verified with a dynamic testing procedure that the frequency response of the Statham transducer plus the cannula was adequate to measure fluctuations in balloon pressure to the required accuracy. 11, 12 In parts I and II, QVR balloons were implanted via a median sternotomy and pericardiotomy. The QVR balloon was placed over the heart to completely envelop both ventricles and secured to the atrioventricular groove. In part II, the QVR portacath was tunneled through the fifth intercostal space into the left anterior chest wall. A separate 3-cm chest wall incision was made to secure the port. The sternum and port incision were then closed in layers.
Quantitative Ventricular Restraint
Individual restraint levels were defined by the maximum pressure applied by the balloon to the epicardium, given a constant volume of saline inside the balloon. Maximum balloon pressure occurred at end diastole, the time point when the heart is largest in volume. To change restraint level, volume was added or removed from the balloon. Fluid was removed to lower the restraint level or added to raise the restraint level while balloon pressure was monitored in real time. To define an arbitrary maximum restraint level applied to a given subject without tamponade, we injected saline into the balloon until mean aortic pressure decreased by 10 mm Hg. We defined this restraint level as P max . At restraint levels higher than P max , tamponade physiology prevailed. We recorded data at 4 sequential restraint levels: 0 (baseline), 1/3 P max , 2/3 P max , and P max .
Heart Failure Model
A postinfarction ovine model of HF, described by Moainie et al, was used. 13 This model includes many of the features of ischemic human dilated cardiomyopathy, which includes global increase in LV EDV and end-systolic volumes and sphericity index and reductions in systolic wall thickening and EF. A total of 11 ovines (5 in part I; 6 in part II) underwent D1/D2 ligation for this study. A left anterior thoracotomy was performed through the 4th intercostal space. D1 and D2 were identified and ligated with 4-0 polypropylene sutures. The thoracotomy was closed in layers. A single chest tube was introduced through a separate incision and removed before extubation. Serial echocardiography was performed on all ovines preinfarction and then weekly. HF, defined as an LV EF Ͻ35% and a 100% increase in LV EDV, developed in all ovines 8 weeks postinfarction (Table 1) .
Anesthesia and Postoperative Care
For coronary ligation and balloon implantation, animals were presedated with Telazol (Wyeth)(4.4 mg/kg) and endotracheally intubated. Anesthesia was maintained with 1% to 2% isofluorane. A 16-gauge intravenous line was placed in the left external jugular vein for access and measurement of central venous pressure. Animals received magnesium (2 g intravenously), amiodarone (1.5 mg/kg intravenously), and lidocaine (3 mg/kg intravenously) before infarction and an infusion of amiodarone (0.01 mg/kg per min) and lidocaine (2 mg/min) for 60 minutes afterward. Animals received buphrenorphine (5 g/kg intramuscularly every 12 hours for 2 days) for pain control and cefazolin (4 mg/kg intramuscularly every 12 hours for 2 days) for antibiotic prophylaxis.
Pressure-Volume Analysis
In part I, 5 HF and 5 normal ovines were placed under general anesthesia and underwent QVR balloon placement. An electromagnetic aortic flow probe (Carolina Medical Electronics, King, NC) was placed to measure aortic flow. High-fidelity micromanometers (Millar Instruments, Houston, Tex) were placed in the LV and ascending aorta via the right and left femoral arteries. An 8F conductance catheter for LV volume measurement (Webster Laboratories, Baldwin Park, Calif) was placed via the right carotid artery. 14 -16 A 20-mL balloon occluder was introduced into the inferior vena cava via the right femoral vein. All electrocardiographic and hemodynamic signals were digitized at 200 Hz.
For each subject, all hemodynamic signals were recorded at 4 sequential ventricular restraint levels (0, 1/3 P max , 2/3 P max , and P max ) over 20 beats. At each restraint level, a caval occlusion was performed with the balloon occluder. All data were collected with the ventilator off to avoid respiratory variations.
All data were analyzed on a microcomputer with MATLAB (The Mathworks, Natick, Mass). End diastole was defined as the time point in the cardiac cycle that corresponded to the R-wave on the ECG. This point corresponds closely to the closing of the mitral valve. Begin-ejection was defined as the point at which aortic flow first becomes non-zero. End systole was defined as the point at which aortic flow fell to zero after the beginning of ejection. Hemodynamic signals were ensemble-averaged over 10 beats. P tm across the heart wall was defined as the LV pressure minus the epicardial pressure (measured by the balloon). The transmural tension-time index (T t TI) was calculated by integration of P tm with respect to time over the cardiac cycle. The end-systolic pressure-volume relationship was then calculated from the caval occlusion data, by the procedure of Kono et al. 17 We then determined the transmural pressure-volume area (P t VA), stroke work (area circumscribed by the pressure-volume loop), potential energy (P t VA Ϫ stroke work), and mechanical efficiency (ratio of stroke work to P t VA) for each restraint level. 18 
Serial Echocardiography
In part II, quantitative 2-dimensional transthoracic echocardiography (Cypress Acuson, Siemens Medical Solutions, Malvern, Pa) with a 3.5-MHz probe was performed preinfarction and then weekly in all animals throughout the study period. Parasternal long-axis images and short-axis images of the LV to the tips of the papillary muscles were obtained. LV EDV and end-systolic volumes were calculated by Simpson's rule with the Cypress Acuson. LV EF was calculated as the ratio of the difference of EDV and end-systolic volume to EDV. 19 All echocardiograms were analyzed by an investigator blinded to the treatment group and time.
Statistics
All data are expressed as meanϮSD. Means between groups were compared with the Student t test. Repeated measures data were assessed with a doubly multivariate repeated measures design to control for the interrelatedness of our outcomes. Statistics were performed with SPSS 12.0 (Chicago, Ill). Results with PϽ0.05 were considered significant.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
Quantitative Ventricular Restraint
By measuring balloon pressure via the portacath, real-time intraoperative and postoperative measurement of ventricular restraint level was possible. Representative intraoperative tracings for aortic flow, aortic pressure, LV pressure, epicardial (balloon) pressure, and P tm are depicted in Figure 2 . Epicardial pressure applied to the heart varied throughout the cardiac cycle, peaked at end diastole, decreased rapidly during systole after the onset of ejection, and then increased rapidly during diastole as blood filled the heart. Restraint level was adjusted by the injection or withdrawal of saline from the balloon lumen via the access port. Injected volume of saline varied from 0 and 360 mL as needed to attain the desired restraint level. The mean P max for all ovines in this study was determined to be 8.0Ϯ0.1 mm Hg. No difference was observed in P max between normal and HF ovines. 
Part I
Baseline Differences in LV Mechanics and Energetics Between Normal and HF Ovines
Left ventricular size, mechanics, and energetics observed in the normal and postinfarction HF ovine model are tabulated in Table 1 . HF ovines had enlarged hearts with depressed contractility, elevated diastolic pressures, and impaired mechanical efficiency. HF ovines demonstrated depressed LV EF (Ͻ35%) and higher LV EDV (increase of 62.1 mL or 102%). Decreased contractility was manifested by a decreased end-systolic elastance (E es ) and a rightward shift in the end-systolic pressure-volume relationship. There was no statistically significant difference in stroke volume or cardiac output. Although there was no difference in mean P tm , P tm was elevated throughout diastole in HF ovines compared with controls. End-diastolic P tm was 3.7 mm Hg (65%) higher in HF ovines compared with normal ovines. In HF ovines, potential energy was 471 mm Hg-mL/beat (82%) higher secondary to increased LV volume. HF hearts were mechanically less efficient than normal hearts. No statistically significant difference existed in stroke work, P t VA, or T t TI between HF and normal ovines.
Immediate Effects of Ventricular Restraint on Left Ventricular Mechanics and Energetics
The immediate effects of ventricular restraint on LV mechanics and indices of myocardial energetics in HF and normal ovines are illustrated in Figure 3 .
Transmural Myocardial Pressure
Ventricular restraint decreased P tm throughout the cardiac cycle for both HF and normal ovines. The greatest decrease in P tm occurred during diastole, with maximal reduction at end diastole. Figure 3A demonstrates the percent reduction in mean P tm as a function of restraint level for normal and HF ovines. In HF ovines, mean P tm was significantly reduced by 7%, 19%, and 35%, respectively, at each of the 3 sequentially increasing restraint levels from baseline (PϽ0.05). Ventricular restraint reduced P tm equally in normal and HF ovines. Figure 3B demonstrates the percent reductions in P tm during systole, diastole, and at end diastole in HF ovines. The greatest reduction was noted at end diastole. EDP tm decreased by 27%, 30%, and 36%, respectively, for all 3 sequentially increasing restraint levels from the baseline (PϽ0.05).
Indices of Myocardial Energetics
Ventricular restraint decreased T t TI and P t VA in both normal and HF ovines ( Figure 3, C and D) . In HF ovines, T t TI decreased by 12%, 19%, and 33%, respectively, for all 3 increasing restraint levels tested from the baseline (PϽ0.05). In HF ovines, P t VA decreased by 20%, 27%, 51%, respectively, for all 3 increasing restraint levels from baseline (PϽ0.05). Ventricular restraint reduced T t TI and P t VA equally in normal and HF ovines. In HF ovines, ventricular restraint improved mechanical efficiency ( Figure 3E ). Mechanical efficiency improved from 55% at baseline to 63% at P max (PϽ0.05). In normal ovines, ventricular restraint had no effect on mechanical efficiency (Pϭ0.65). 
End-Systolic Elastance
In both normal and HF ovines, ventricular restraint had no immediate effect on E es ( Figure 3F ). In HF ovines, E es was 1.55Ϯ0.38 mm Hg/mL at baseline and 1.61Ϯ0.39 mm Hg/ mL at P max . In normal ovines, E es was 2.54Ϯ0.37 mm Hg/mL at baseline and 2.37Ϯ0.39 mm Hg/mL at P max . Similarly, ventricular restraint had no effect on the volume-axis intercept in both normal and HF ovines. Thus, ventricular restraint did not affect contractility in the short term as measured by end-systolic pressure-volume relationship.
Immediate Adverse Effects of Ventricular Restraint on Hemodynamics
Mean aortic pressure, heart rate, stroke volume, cardiac output, LV end-diastolic pressure, and central venous pressure in HF ovines for each restraint level are summarized in Table 2 . As expected, at high restraint levels, restrictive physiology prevailed as demonstrated by a decrease in mean aortic pressure and cardiac output with a concomitant increase in LV EDP and central venous pressure. At low restraint levels, however, aortic pressure and cardiac output were unchanged.
Optimization of Ventricular Restraint Level
Increasing levels of wrap tightness caused greater decreases in P tm and indices of MV O 2 . Very high levels of restraint impaired systemic hemodynamics. This suggests that an optimal restraint level exists, where the reduction in P tm and MV O 2 is maximized while the effect on systemic hemodynamics is minimized. Ideally, this restraint level would correct pathologically elevated stress and strain seen in HF. Figure 4A and 4B illustrate the short-term effect of ventricular restraint on LV EDP tm and potential energy in HF ovines. The shaded regions in Figure 4 , A and B, indicate the normal range of LV EDP tm and potential energy found in ovines. Figure 4C illustrates LV EDP tm and mean aortic pressure, normalized to baseline, for the 4 different restraint levels studied.
At a restraint level of 1/3 P max (3 mm Hg), previously elevated LV EDP tm and potential energy were reduced and corrected to normal levels, whereas mean aortic pressure remained unaffected until restraint levels were greater than 1/3 P max . Thus, a restraint level of 1/3 P max (3 mm Hg) corrected abnormally elevated LV EDP tm and potential energy with no effect on mean aortic pressure. These data suggest that a restraint level of 3 mm Hg is the optimal physiological restraint level for these HF ovines.
Part II
Long-Term Optimized Ventricular Restraint Therapy
QVR was then applied at the optimal therapeutic restraint level of 1/3 P max (3 mm Hg) in 3 HF ovines for 2 months and compared with controls that received no treatment over the same time period. Figure 5 , A and B, demonstrates the effect of optimized restraint on LV EDV and LV EF in these ovines compared with controls. At the time of QVR balloon implantation, both groups demonstrated dilated cardiomyopathy, with increased LV EDV and depressed LV EF. Over the subsequent 2-month period, QVR significantly decreased LV EDV from 130Ϯ22 mL to 91Ϯ18 mL (Ϫ30%, PϽ0.05), and improved LV EF from 27Ϯ3% to 43Ϯ5% (PϽ0.05). In contrast, control animals developed increasing measures of HF, which included an increase of LV EDV from 113Ϯ19 mL to 168Ϯ7 mL (49%, PϽ0.05) and a decrease of LV EF from 33Ϯ2% to 19Ϯ8% (PϽ0.05). LV EDV was 77 mL lower (Ϫ90%, PϽ0.05) and LV EF was 24% higher (PϽ0.05) in QVR ovines compared with controls. In QVR ovines, LV EDV decreased 21 days after the initiation of QVR therapy (PϽ0.05), and LV EF improved 42 days after initiation of QVR therapy (PϽ0.05). Furthermore, restraint level decreased as the heart decreased in size ( Figure 5C ). As restraint level decreased, reverse remodeling slowed, as measured by the rate of change of LV EDV over time.
Discussion
Previous studies have demonstrated the potential for ventricular restraint to prevent and reverse pathological LV remodeling. [1] [2] [3] [4] [5] [6] [7] [8] 20, 21 To date, no study has evaluated LV mechanics in restraint or the effect of adjustable restraint. Current ventricular restraint techniques, such as the Acorn Cardiac Support Device (Acorn Cardiovascular, St. Paul, Minn) and the Paracor (Paracor Medical Systems, Sunnyvale, Calif), do not allow for either the quantitative adjustment of restraint level or the measurement of P tm . 3, 10 A standard for wrap tightness does not exist. Surgeons are instructed to apply the Acorn Cardiac Support Device in such a way that it fits not too loosely and not too tightly, but "snugly." Once wrapped at the initial procedure, the restraint wrap is constant and unchanging even as the heart undergoes reverse remodeling. To address these limitations, we used a half-ellipsoid, fluid-filled epicardial balloon. Restraint therapy ultimately acts on the heart via application of either shear stresses (tangential forces) or normal stresses (perpendicular forces) to the epicardium. Because neither is quantified with current restraint therapy, a separation of wrap mechanics from ventricular mechanics is neither possible nor measurable. The QVR balloon essentially introduces a fluid layer as the sole means to implement ventricular restraint. Because fluids by definition cannot sustain shear stresses, the QVR balloon affects ventricular restraint by normal forces only. Other restraint devices apply some degree of shear stress. Sheer stress does not contribute to reverse remodeling but may contribute to cardiac restriction. The QVR balloon thus provides a methodology to definitively understand and quantify the effect of ventricular restraint by measurement of those normal forces (the only stresses exerted) on the epicardium.
With this technique, we demonstrated that ventricular restraint decreases P tm throughout the cardiac cycle. The greatest reduction in P tm occurred during diastole, with the maximum reduction at end diastole. The largest reduction in EDP tm occurred when restraint level was increased from 0 (baseline) to 1/3 P max (3 mm Hg). As restraint level increased, further decreases in P tm were more pronounced during systole with relatively modest further reductions during diastole. Thus, at low restraint levels, ventricular restraint affected P tm primarily during diastole. At high restraint levels, ventricular restraint acted primarily during systole to decrease P tm , consistent with early restrictive physiology.
Important concerns with restraint therapy are cardiac restriction and impairment of coronary blood flow. The maximum applicable restraint level will be limited by the restrictive effect of the restraint device, primarily on the lowpressure right ventricle. It is well known that elevated epicardial pressure impairs right ventricular filling and atrioventricular coupling. In the present study, high levels of restraint (8 mm Hg) decreased cardiac output and increased central venous pressure. At low restraint levels (3 mm Hg), no evidence of cardiac restriction was seen (Table 2) . Previous studies have demonstrated that elevated pericardial pressure also decreases coronary blood flow through either a reduction of coronary perfusion pressure or an increase in coronary vascular resistance. 22, 23 This effect, however, primarily only occurs in low cardiac output states or very high pericardial pressures (Ͼ15 mm Hg). Although we did not measure coronary blood flow, at our low levels of epicardial pressure we found no evidence of significant ischemia, as contractility was not impaired and LV function improved. Excessive ventricular restraint may impair coronary blood flow and be an important concern, particularly in patients with underlying coronary artery disease and subclinical myocardial ischemia.
Because wall stress is directly proportional to P tm , these results suggest that ventricular restraint reduces wall stress. If ventricular restraint reduces wall stress, a major determinant of MV O 2 , one would expect to see a decrease in O 2 uptake. In this study, we show that MV O 2 indices are acutely decreased secondary to a decrease in P tm and LV unloading. Because of higher filling volumes, dilated cardiomyopathic hearts have higher potential energy (or internal work) compared with normal controls. These data show that in cardiomyopathy, ventricular restraint unloads the LV and decreases potential energy more significantly than stroke work. Mechanical efficiency is thus improved [stroke workϬ(stroke work ϩ potential energy)] in cardiomyopathic hearts. Conversely, in normal hearts with typical LV loading, ventricular restraint decreases potential energy and stroke work equally and thus has no effect on mechanical efficiency.
Comparing normal to cardiomyopathic hearts, we found that ventricular restraint decreased P tm , T t Ti, and P t VA equally at the levels we tested. We conclude that LV size, load, and contractility were not determinative factors in the reduction of P tm and MV O 2 at the restraint levels we tested. We also conclude that the mechanical effect of restraint is primarily determined by wrap mechanics and not by the contractile or mechanical properties of the heart itself. Standardization of wrap mechanics should thus allow for standardization of therapy for patients.
An interesting question is whether optimization to the highest physiological restraint level may improve therapeutic efficacy. By application of optimal restraint over a 2-month period, we demonstrated a 30% reduction in LV EDV compared with baseline in ovines. Progressive LV dilatation was prevented and reversed, as LV EDV was 90% higher in controls after 2 months. In comparison, Saveedra et al found a 19Ϯ4% reduction in LV EDV over 6 months in a canine model of HF that used the Acorn Cardiac Support Device. 8 Other studies in animal models demonstrated prevention rather than reversal of LV dilation. 5, 6 In human studies, modest improvements in LV EDV have been found. 24 Reverse remodeling may be dependent on restraint level. At low restraint levels, ventricular restraint may provide simple containment. At such levels of restraint, progression of disease may be halted but reversal of dilatation may not necessarily be enabled. Our results suggest that at higher restraint levels ventricular restraint contains and unloads the LV, which leads to decreased LV size. The greater decrease in LV EDV seen in this study compared with previous studies may be caused by the optimized restraint level. The data demonstrate that restraint level is not constant as the LV remodels. We found that pressures measured in the QVR balloon decreased with time ( Figure 5C ). As the LV undergoes reverse remodeling and becomes smaller, the ventricular wrap stays constant. Our conclusion is that a smaller LV effectively loosens the ventricular restraint wrap and restraint level decreases. In addition, as the restraint level decreased, reverse remodeling slowed (as measured by the rate of change of LV EDV over time) ( Figure 5C ). This finding suggests that restraint level is an important determinant of reverse remodeling efficiency. To maximize therapeutic efficacy, periodic adjustment of wrap tightness to maintain the most effective physiological restraint level may be beneficial. 
